Impact of anti-HER2 therapy on overall survival in HER2-overexpressing breast cancer patients with brain metastases

被引:0
作者
R Bartsch
A Berghoff
U Pluschnig
Z Bago-Horvath
P Dubsky
A Rottenfusser
C DeVries
M Rudas
F Fitzal
K Dieckmann
R M Mader
M Gnant
C C Zielinski
G G Steger
机构
[1] Medical University of Vienna,Clinical Division of Oncology, Department of Medicine I
[2] Comprehensive Cancer Centre,Department of Pathology
[3] Medical University of Vienna,Department of Surgery
[4] Medical University of Vienna,Department of Radiotherapy
[5] Medical University of Vienna,undefined
[6] Medical University of Vienna,undefined
来源
British Journal of Cancer | 2012年 / 106卷
关键词
brain metastases; breast cancer; HER2-positive disease; lapatinib; trastuzumab;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:25 / 31
页数:6
相关论文
共 350 条
  • [1] Aoyama H(2006)Stereotactic radiosurgery plus whole-brain radiation therapy JAMA 295 2483-2491
  • [2] Shirato H(2009) stereotactic radiosurgery alone for treatment of brain metastases: a randomized controlled trial BMC Cancer 9 367-317
  • [3] Tago M(2007)Predicting for activity of second-line trastuzumab-based therapy in her2-positive advanced breast cancer J Neurooncol 85 311-2977
  • [4] Nakagawa K(2003)Trastuzumab prolongs overall survival in patients with brain metastases from HER2 positive breast cancer Cancer 97 2972-216
  • [5] Toyoda T(1993)Central nervous system metastases in women who receive trastuzumab-based therapy for metastatic breast carcinoma J Neurosurg 79 210-9
  • [6] Hatano K(1980)Surgical treatment of multiple brain metastases Int J Radiat Oncol Biol Phys 6 1-265
  • [7] Kenjyo M(2004)The palliation of brain metastases: final results of the first two studies by the Radiation Therapy Oncology Group Radiother Oncol 71 259-1777
  • [8] Oya N(2005)Survival following whole brain radiation treatment for cerebral metastases: an audit of 747 patients Ann Oncol 16 1772-543
  • [9] Hirota S(2008)Isolated central nervous system metastases in patients with Her2-overexpressing breast cancer treated with first-line trastuzumab-based therapy Breast Cancer Res Treat 112 533-643
  • [10] Shioura H(2004)A phase III randomized comparison of lapatinib plus capecitabine Br J Cancer 91 639-1248